|
HS Code |
380344 |
| Cas Number | 1192-34-3 |
| Molecular Formula | C3H4N2O |
| Molecular Weight | 84.08 |
| Iupac Name | 3-Aminoisoxazole |
| Synonyms | 3-Isoxazolamine; Isoxazol-3-amine |
| Appearance | White to off-white solid |
| Melting Point | 187-189 °C |
| Solubility In Water | Moderate |
| Smiles | NC1=NOC=C1 |
| Inchi | InChI=1S/C3H4N2O/c4-3-1-2-6-5-3/h1-2H,4H2 |
As an accredited 3-Aminoisoxazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle labeled "3-Aminoisoxazole, 25g", features hazard symbols, CAS number, lot number, and safety instructions. Sealed cap. |
| Shipping | 3-Aminoisoxazole is shipped in tightly sealed containers to prevent contamination and moisture exposure. It is handled as a chemical reagent, compliant with all regulatory and safety guidelines. Packages are clearly labeled, with appropriate hazard documentation included. Shipping typically occurs under ambient conditions unless otherwise specified by regulatory requirements or customer instructions. |
| Storage | 3-Aminoisoxazole should be stored in a tightly sealed container in a cool, dry, and well-ventilated area, away from sources of ignition, heat, and direct sunlight. Avoid exposure to moisture and incompatible materials such as strong oxidizing agents. Clearly label the container and ensure that only trained personnel have access. Follow all relevant safety guidelines and regulations for chemical storage. |
Applications of 3-Aminoisoxazole in Industrial Manufacturing3-Aminoisoxazole serves as a specialized chemical intermediate, contributing to several focused downstream manufacturing sectors due to its unique heterocyclic amine structure. As a producer of this compound, we maintain active engagement with industry partners within key regulated areas, ensuring our material’s consistency and utility for applications demanding strict compliance, precise formulation, and reliable process integration. 1. Pharmaceutical Active Ingredient SynthesisPharmaceutical manufacturers utilize 3-Aminoisoxazole during heterocycle formation steps, where its amine group facilitates nucleophilic substitution or ring-closing reactions required in the synthesis of several investigational and approved active pharmaceutical ingredients (APIs), including non-classical nucleosides and kinase inhibitors. Integration of this intermediate occurs primarily in small-scale cGMP-validated multi-step synthesis, where control of starting material quality and traceability is critical to downstream purity and regulatory submissions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Intermediate Manufacturing3-Aminoisoxazole is selected in plant protection product synthesis as a reactive intermediate in pyrazole, isoxazoline, and related scaffolds frequently applied in the crop protection sector. Downstream, formulators depend on the reproducibility of this building block for agrochemical actives requiring high selectivity/autecology. Compliance with global agricultural chemical legislation mandates traceability of all intermediates. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Dye and Pigment Raw MaterialChemical dyestuff manufacturers employ 3-Aminoisoxazole as a controlled amination source during synthesis of high-purity azo and isoxazole dyes, which require a consistent electron-donating group to achieve specific color characteristics and solubility profiles. Quality consistency ensures that batch-to-batch color deviation and unwanted side-reactions, which lead to off-shade or insoluble pigment fractions, remain within industry-tolerable limits. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Fine Chemical Synthesis for Research and DiagnosticsProducers of diagnostic reagents and preparative fine chemicals integrate 3-Aminoisoxazole as an essential coupling agent or core fragment in laboratory-scale synthesis of biochemical probes and reference standards. These components often demand extremely stringent impurity profiles, with validated analytical traceability back to raw material sources. Routine production supplies universities, biotech labs, and certified GLP facilities for regulated research and diagnostic workflows. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3-Aminoisoxazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Manufacturing 3-Aminoisoxazole at scale comes with its own set of challenges and expectations, both from a chemical engineering standpoint and from the demands of our partners in pharmaceuticals, fine chemicals, and research institutions. Experience has taught us that purity, consistency, and prompt, transparent feedback set apart a trusted supplier from the ordinary. We focus on producing 3-Aminoisoxazole because it occupies an important niche in synthetic chemistry and drug development, and it does so without the ambiguities found in some less-defined heterocycles.
Our production process begins with tightly controlled raw material sourcing. We draw from long-standing relationships with reagent suppliers, all subjected to strict quality checks. Small issues during preparation, like minor temperature shifts or unexpected humidity changes, can spell trouble for the final yield. Over the years, every batch gives us new insights into perfecting reaction conditions. Our team relies not just on modern instrumentation—HPLC, NMR, FTIR—but also hard-earned experience to maintain reliable output. Each kilogram is the outcome of dozens of checks, starting with the first mix and stretching through crystallization to final packaging.
3-Aminoisoxazole is usually supplied as an off-white to light yellow crystalline solid, though batch-to-batch color variation can reveal tiny changes in starting materials or reaction byproducts. It’s not a detail we overlook—if a lot turns out a touch darker than expected, we investigate it, because end-users in medicinal chemistry or agrochemical research will notice as quickly as we do. Over time, we’ve tightened controls well beyond normal assay thresholds, aiming for purities above 99%, with moisture content consistently managed to support long shelf stability and reproducibility in downstream reactions.
Scientists value 3-Aminoisoxazole as a building block, particularly for applications where the isoxazole ring brings unique properties to target molecules. Unlike more common amines or other isoxazole derivatives, the 3-amino position opens up synthetic flexibility. Medicinal chemists often seek to introduce this group in the early or late phase of scaffold design, giving rise to analogues with potential for anti-inflammatory, antiviral, or even anticancer properties. Our laboratory clients have used it in small molecule libraries, enzyme inhibitors, and test frameworks for SAR (structure-activity relationship) studies.
3-Aminoisoxazole carries its own quirks. Its amino group can be reactive under certain condensation conditions, but it’s generally robust under standard coupling protocols. This chemical stability means customers encounter fewer surprises. Where other amines may oxidize or decompose after only a few weeks, our properly packaged 3-Aminoisoxazole remains usable for many months. By shipping batches with tight controls on residual solvents and using inert packaging, we reduce the risk of moisture uptake or breakdown—a lesson learned from seeing what happens in less controlled supply chains.
Over the years, some chemists have expressed frustration at off-grade lots from traders or repackagers. With vague labeling and uneven documentation, researchers sometimes burn through precious resources troubleshooting their reactions, only to learn later of out-of-spec contaminant levels or unknown impurities from intermediates. These stories fuel our insistence on documentation. We attach a full certificate of analysis to every shipment, covering assay, melting point, residual solvent traces, and even infrared spectra if the client requests added peace of mind.
The chemical world offers many ways to introduce amino groups onto five-membered heterocycles, but not all paths give the same flexibility downstream. 3-Aminoisoxazole stands apart from its more substituted cousins, like 5-amino or 4-aminoisoxazole, due to the unique electronics of the ring position. These subtle changes influence reactivity toward alkylation, acylation, and heterocycle formation. Immediately, medicinal chemists see the impact on selectivity, offering routes missed by other aminated scaffolds. As a manufacturer, we’ve been drawn into countless conversations with customers seeking one nitrogen position over another and can attest to the experimental differences small structural changes bring.
Compared with simple aromatic amines (think aniline, pyridine analogs), 3-Aminoisoxazole integrates into molecular frameworks with less risk of unwanted oxidation or side reactions. Its solubility profile tends to be more predictable, especially in polar aprotic solvents. Researchers working in peptide and nucleoside chemistry appreciate this reliability. This is not a generic intermediate—it’s a tool for pushing boundaries in chemical design.
Product specifications are more than just a box-check. Our QC team reviews material properties against industry-accepted standards but also listens to development chemists who share specific bottlenecks or analytical challenges. Suppose a customer faces crystallization difficulties due to trace oiling from an impurity. In that case, we will adjust purification protocols, narrowing solvent gradients or reworking isolation methods, until the product meets both our standards and those of the end-user. This feedback loop does not happen through generic intermediaries or abstracted trading channels. It comes down to engineers, operators, and chemists all working under one roof.
To reduce the risk of batch-to-batch variation, our operation employs semi-continuous production for larger orders, moving away from fully batch-based processes whenever possible. Automated feed controls track reagent amounts, reducing manual error. These investments grew out of hard lessons from earlier years, when hand-operated charging led to minor but frustrating shifts in product consistency. Modernization here does not replace a trained eye; it complements it. Our team cross-references digital logs with physical samples, pulling historical data for trend analysis and quick remediation if anything seems off.
A common question among researchers concerns potential metal contamination or residual byproducts from catalysts sometimes used in isoxazole synthesis. We opted early on for a metal-free protocol, steering clear of transition metal salts that can linger, even after careful washing. Avoiding these agents simplifies downstream purification for clients who operate in regulated environments, where every trace element can mean days of extra analytical documentation. Whenever updates emerge in the literature—newer, cleaner reagents, for example—we pilot them internally before amending our standard operating procedures.
Over the years, our journey with 3-Aminoisoxazole has grown from modest quantities for local university projects to worldwide distribution at research and process scales. Some of our most productive partnerships have come from contract synthesis programs, where our technical input supports the creation of novel derivatives or addresses unique solubility or compatibility requests.
Direct communication has saved more than one project from avoidable delays. Recently, a team working on kinase inhibitors needed material with atypical particle sizing for specialized analytical protocols. We worked together with their scientists, adjusting grinding and sieving steps until the material matched their expectations. Every successful handoff comes from respecting the researcher’s perspective as much as our own interests in process simplicity.
This attitude has ripple effects. By producing consistently high-purity material, we lower the need for excess controls and downstream purification on our clients’ end. That saves researchers time and cost, enabling more rapid iteration during early-stage drug discovery or advanced material synthesis. For those scaling from gram to several kilograms, a consistent source means fewer hiccups and faster path to proof of concept.
Chemicals like 3-Aminoisoxazole deserve respect, not only for their reactivity but also their handling requirements. Years in the industry have shown us that even seemingly routine compounds carry environmental and safety risks if not managed responsibly. Our facility follows a strict line on waste management and solvent recycling, so each batch generates less effluent and hazardous residue. Routine environmental audits verify safe operation and guide continual improvement, particularly as we adapt to evolving regulations.
For our internal teams, experience reinforces that thorough training and procedural discipline forestall most incidents. Leak prevention comes down to properly maintained equipment, clear signage, and ongoing operator education. Shortcuts or overconfidence quickly reveal themselves in near-miss reports, which prompt us to update procedures so each subsequent run is safer and more consistent. By prioritizing safety as much as quality control, we provide peace of mind to customers and our own employees.
A surprising amount of insight comes from batch records and customer outcomes. Each feedback cycle reveals patterns in potential byproducts, shifts in physical form, or fine differences in melting point. We log these as part of our continuous improvement philosophy, ensuring small gains compound over time. Longstanding clients sometimes request historical lot information to validate experimental data—this transparency reinforces trust.
Frequently, attention goes to supply chain reliability. Our schedule flows from raw material forecasting, seasonal price shifts on select precursors, and real-time production tracking. Lessons from occasional global shortages have reinforced the benefit of flexible production timelines and secondary sourcing. Clients who faced delayed timelines with traders or overextended distributors rarely return to such models after experiencing direct-from-source supply.
One key benefit of dealing with a manufacturer, rather than an intermediary, is the direct link to the technical people who run the plant. Every inquiry gets routed to someone who has either made the compound or overseen QC at scale, not just an account manager referencing a data sheet. This difference matters when a researcher faces an unexpected IR band or faint impurity in LC-MS results. We’ve found that these real-world interactions speed up problem-solving, leading to stronger, smoother project outcomes.
This human element builds long-term customer loyalty. Regular visits from partners who have used our material in successful scale-ups let us see the impacts of our work beyond our factory gates. It also holds us accountable: each positive update is a motivator, each rare complaint a call to improve further.
Global competition does not rest. We evaluate emerging synthetic methodologies and automation tools, not just to cut costs, but to improve reproducibility and reduce environmental impact. A responsive and forward-looking approach allows us to support both routine orders and groundbreaking research into entirely new compound classes. Our R&D team monitors the scientific literature for alternative feedstocks or more sustainable approaches to heterocycle synthesis, ready to pivot production practices as soon as robust, scalable pathways appear.
It’s clear to us that 3-Aminoisoxazole has secured a role as a crucial intermediate—not just for our clients but also for our own process innovation efforts. We test each improvement with small pilot runs before expanding changes to commercial scale, protecting both product quality and client success. No one on our team views this compound as just another item in a catalogue.
After years manufacturing 3-Aminoisoxazole, we see more than a chemical: it represents trust between supplier and customer, and a shared drive for scientific and industrial progress. Each lot embodies careful sourcing, a commitment to safety, and deep attention to detail. The working relationships forged through years of feedback and support matter at least as much as the specifications on a certificate of analysis.
Whether you are in drug discovery, advanced research, or novel material development, our focus remains to deliver a product that stands up to real-world scrutiny. It is this ongoing dialogue with scientists and engineers—built upon honest reporting and a readiness to solve problems in real time—that keeps our quality high and our reputation strong. Working with us means more than ticking a box for supply; it means having a partner as invested in your success as you are.